This is after patient groups with rare diseases have been squeezed when new, expensive medicines have not been subsidized. Among other things, there have been reports of people who have moved abroad to be able to afford their medicine.
– There are more and more orphan drugs, more and more groups are covered, so we want a system that is even more accurate, says Minister of Social Affairs Lena Hallengren (S), to the radio.
In recent years, the state’s costs for medicines have increased, and the goal of TLV’s investigation is to ensure that resources are used in the best possible way.